OA
ORBIMED ADVISORS LLC
DELAYED 1 MONTH
Director; Director, 10% Owner
Q32 Bio Inc.
Scribe Therapeutics, Inc.
Shattuck Labs, Inc.
Sionna Therapeutics, Inc.
Filings
5
Companies
4
Latest
Jul 27, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
89
Scribe Therapeutics, Inc.
ORBIMED ADVISORS LLC
Director
Purchase
$15.0M
1,000,000 sh
Jul 29 10:47 PM
Jul 27, 2026
82
QTTBCLUSTER 2
Q32 Bio Inc.
ORBIMED ADVISORS LLC
Director, 10% Owner
Purchase
$15.0M
1,875,000 sh
Jun 2 1:13 AM
May 28, 2026
50
SIONCLUSTER 2
Sionna Therapeutics, Inc.
ORBIMED ADVISORS LLC
Director
Sale
$4.5K
101 sh
May 30 12:57 AM
May 27, 2026
62
Sionna Therapeutics, Inc.
ORBIMED ADVISORS LLC
Director
Sale
$8.5M
184,639 sh
May 11 10:58 PM
May 11, 2026